Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|June 10, 2012

ADA Slideshow

View some of the photos from the American Diabetes Association's 72nd Scientific Sessions.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Patient and caregiver | Image Credit: © manassanant -stock.adobe.com

Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma

ByMaggie L. Shaw

June 26th 2026

Dr Irina Murakhovskaya | Image Credit: Montefiore Einstein

ENERGY Trial Shows Early Fatigue Benefit With Nipocalimab in wAIHA: Irina Murakhovskaya, MD

ByBrooke McCormick,Irina Murakhovskaya, MD

June 26th 2026

Dr Julie Kanter | Image Credit: Inherited Blood Disorders

SCD Trials Should Shift Toward Broader End Points, Real-World Monitoring to Expand Eligiblity: Julie Kanter, MD

ByBrooke McCormick,Julie Kanter, MD

June 25th 2026

Dr Claire Harrison | Image Credit: Guy's and St. Thomas' NHS Foundation Trust

Early SENTRY Data Suggest Benefit of Selinexor-Ruxolitinib in JAK Inhibitor–Naive Myelofibrosis: Claire Harrison, MD

ByBrooke McCormick,Claire Harrison, MD

June 25th 2026

Acuteleukemiawordcloud | Image Credit: © ibreakstock-stock.adobe.com

Venetoclax Combinations Show Promise Across ALL/AML

ByMaggie L. Shaw

June 25th 2026

Trending on AJMC

FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

More Potent and Tolerable, Azenosertib Advances as the Leading WEE1 Inhibitor

Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma

Health Care Spending to Hit $9 Trillion by 2034, According to New Analysis